Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy

Antiviral Therapy

Volumn 16, Issue 4, 2011, Pages 591-596

  Wyatt, Christina M ^a   Hoover, Donald R ^b   Shi, Qiuhu ^c   Tien, Phyllis C ^d,e   Karim, Roksana ^f   Cohen, Mardge H ^g   Goderre, Johanna L ^h   Seaberg, Eric C ^h   Lazar, Jason ⁱ   Young, Mary A ^j   Klotman, Paul E ^a   Anastos, Kathryn ^k  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g Jr Hospital of Cook County   (United States)

^h JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ SUNY Downstate Medical Center   (United States)

^j GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^k ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALBUMINURIA; ARTICLE; CAUSE OF DEATH; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MICROALBUMINURIA; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RISK ASSESSMENT; URINALYSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ALBUMINURIA; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROTEINURIA; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 79953156252     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1766     Document Type: Article

References (20)

1. Kimmel PL, Umana WO, Bosch JP. Abnormal urinary protein excretion in HIV-infected patients. Clin Nephrol 1993; 39:17-21. (Pubitemid 23057737)
2. Szczech LA, Grunfeld C, Scherzer R, et al. Microalbuminuria in HIV infection. AIDS 2007; 21:1003-1009. (Pubitemid 46684331)
3. Baekken M, Os I, Sandvik L, Oektedalen O. Microalbuminuria associated with indicators of inflammatory activity in an HIV-positive population. Nephrol Dial Transplant 2008; 23:3130-3137.
4. Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286:421-426. (Pubitemid 32681484)
5. Wyatt CM, Hoover DR, Shi Q, et al. Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection. J Acquir Immune Defic Syndr 2010; 55:73-77.
6. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998; 9:117-125. (Pubitemid 28157608)
7. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470. (Pubitemid 29135798)
8. Cohen MH, French AL, Benning L, et al. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med 2002; 113:91-98. (Pubitemid 34804744)
9. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-612.
10. Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375:2073-2081.
11. Szczech LA, Hoover DR, Feldman JG, et al. Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clin Infect Dis 2004; 39:1199-1206. (Pubitemid 40169320)
12. Gardner LI, Holmberg SD, Williamson JM, et al. Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr 2003; 32:203-209. (Pubitemid 36222723)
13. Estrella MM, Parekh RS, Abraham A, et al. The impact of kidney function at HAART initiation on mortality in HIV-infected women. J Acquir Immune Defic Syndr 2010; 55:217-220.
14. George E, Lucas GM, Nadkarni GN, Fine DM, Moore R, Atta MG. Kidney function and the risk of cardiovascular events in HIV-1-infected patients. AIDS 2010; 24:387-394.
15. Choi AI, Li Y, Deeks SG, Grunfeld C, Volberding PA, Shlipak MG. Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation 2010; 121:651-658.
16. French AL, Gawel SH, Hershow R, et al. Trends in mortality and causes of death among women with HIV in the United States: a 10-year study. J Acquir Immune Defic Syndr 2009; 51:399-406.
17. Szczech LA, Golub ET, Springer G, et al. Highly active antiretroviral therapy reduces urinary albumin excretion in women with HIV infection. J Acquir Immune Defic Syndr 2008; 48:360-361.
18. Siedner MJ, Atta MG, Lucas GM, Perazella MA, Fine DM. Poor validity of urine dipstick as a screening tool for proteinuria in HIV-positive patients. J Acquir Immune Defic Syndr 2008; 47:261-263. (Pubitemid 351172198)
19. Brinkman JW, de Zeeuw D, Lambers Heerspink HJ, et al. Apparent loss of urinary albumin during long-term frozen storage: HPLC vs immunonephelometry. Clin Chem 2007; 53:1520-1526. (Pubitemid 47206350)
20. Gupta SK, Eustace JA, Winston JA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005; 40:1559-1585. (Pubitemid 40720806)